| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.30e-07 | 4 | 88 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | chromatin binding | FOXO3 TPR SP3 ARID1B SIRT2 MLH3 YBX1 LEMD3 RAD21L1 CHD7 MBD6 ARID1A TRIM37 HNRNPD HNRNPU | 7.47e-07 | 739 | 88 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.64e-06 | 6 | 88 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | transcription factor binding | FOXO3 SP3 SIRT2 ZNHIT6 TCERG1 PURA LRP2 CPNE1 TACC2 RFC1 ARID1A MEF2D MED13 HNRNPU | 5.05e-06 | 753 | 88 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 1.92e-05 | 2 | 88 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | poly(C) RNA binding | 1.92e-05 | 2 | 88 | 2 | GO:0017130 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP3 SIRT2 TCERG1 PURA LRP2 CPNE1 TACC2 RFC1 ARID1A MEF2D MED13 | 4.92e-05 | 582 | 88 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 6.43e-05 | 18 | 88 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.57e-04 | 24 | 88 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.66e-04 | 129 | 88 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.40e-04 | 31 | 88 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.10e-04 | 33 | 88 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 5.06e-04 | 417 | 88 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 5.47e-04 | 151 | 88 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.09e-03 | 46 | 88 | 3 | GO:0005245 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.21e-05 | 11 | 88 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | CRD-mediated mRNA stabilization | 1.21e-05 | 11 | 88 | 3 | GO:0070934 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.61e-05 | 12 | 88 | 3 | GO:1900152 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.83e-05 | 37 | 88 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 2.27e-05 | 39 | 88 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 2.51e-05 | 40 | 88 | 4 | GO:1902275 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 2.64e-05 | 14 | 88 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 3.69e-05 | 44 | 88 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic translation | 4.89e-05 | 17 | 88 | 3 | GO:2000767 | |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 6.27e-05 | 98 | 88 | 5 | GO:0008088 | |
| GeneOntologyBiologicalProcess | muscle structure development | SOX6 FBXO40 ARID1B SIRT2 YBX1 LEMD3 LRP2 CHD7 ARID1A MEF2D RYR1 RYR2 HNRNPU | 6.82e-05 | 858 | 88 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | negative regulation of transcription elongation by RNA polymerase II | 8.12e-05 | 20 | 88 | 3 | GO:0034244 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 8.34e-05 | 330 | 88 | 8 | GO:0040029 | |
| GeneOntologyBiologicalProcess | response to caffeine | 9.44e-05 | 21 | 88 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | S-adenosylmethionine biosynthetic process | 1.07e-04 | 4 | 88 | 2 | GO:0006556 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription, elongation | 1.25e-04 | 23 | 88 | 3 | GO:0032785 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.32e-04 | 558 | 88 | 10 | GO:0060537 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX6 FOXO3 TPR SP3 SIRT2 TCERG1 YBX1 RIPPLY2 PURA RFC1 ARID1A TRIM37 HEXIM1 HNRNPU | 1.41e-04 | 1053 | 88 | 14 | GO:0000122 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 1.41e-04 | 356 | 88 | 8 | GO:0098813 | |
| GeneOntologyBiologicalProcess | chromosome organization | TPR ACTR8 ARID1B SIRT2 MLH3 PURA RAD21L1 RFC1 ARID1A HNRNPD HNRNPU | 1.59e-04 | 686 | 88 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.04e-04 | 27 | 88 | 3 | GO:1900151 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.05e-04 | 198 | 88 | 6 | GO:0007605 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 2.34e-04 | 203 | 88 | 6 | GO:0045814 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 2.58e-04 | 293 | 88 | 7 | GO:0032886 | |
| GeneOntologyBiologicalProcess | dendritic transport of ribonucleoprotein complex | 2.67e-04 | 6 | 88 | 2 | GO:0098961 | |
| GeneOntologyBiologicalProcess | dendritic transport of messenger ribonucleoprotein complex | 2.67e-04 | 6 | 88 | 2 | GO:0098963 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | RLF TPR FKBP6 ACTR8 ARID1B SIRT2 NAP1L5 CHD7 ARID1A TRIM37 HNRNPU | 3.09e-04 | 741 | 88 | 11 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 3.23e-04 | 139 | 88 | 5 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 4.08e-04 | 34 | 88 | 3 | GO:0090169 | |
| GeneOntologyBiologicalProcess | chromatin organization | RLF TPR FKBP6 ACTR8 ARID1B SIRT2 NAP1L5 LSM11 CHD7 ARID1A TRIM37 HNRNPU | 4.13e-04 | 896 | 88 | 12 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 5.25e-04 | 37 | 88 | 3 | GO:2000765 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 5.46e-04 | 238 | 88 | 6 | GO:0050954 | |
| GeneOntologyBiologicalProcess | muscle organ development | 5.49e-04 | 436 | 88 | 8 | GO:0007517 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 6.33e-04 | 161 | 88 | 5 | GO:0051592 | |
| GeneOntologyBiologicalProcess | ventricular compact myocardium morphogenesis | 6.35e-04 | 9 | 88 | 2 | GO:0003223 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 6.61e-04 | 40 | 88 | 3 | GO:0071312 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 6.69e-04 | 163 | 88 | 5 | GO:0031507 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 7.34e-04 | 349 | 88 | 7 | GO:0014706 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 8.35e-04 | 465 | 88 | 8 | GO:0007059 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle organization | 8.76e-04 | 44 | 88 | 3 | GO:0060236 | |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 5.24e-05 | 3 | 88 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 1.02e-04 | 110 | 88 | 5 | GO:0120111 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.56e-04 | 73 | 88 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | histone pre-mRNA 3'end processing complex | 2.60e-04 | 6 | 88 | 2 | GO:0071204 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 2.60e-04 | 6 | 88 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | lateral loop | 3.63e-04 | 7 | 88 | 2 | GO:0043219 | |
| GeneOntologyCellularComponent | junctional membrane complex | 6.19e-04 | 9 | 88 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 7.71e-04 | 10 | 88 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | bBAF complex | 7.71e-04 | 10 | 88 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | nuclear periphery | 7.83e-04 | 171 | 88 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 9.00e-04 | 45 | 88 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 9.60e-04 | 46 | 88 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | synaptonemal complex | 9.60e-04 | 46 | 88 | 3 | GO:0000795 | |
| GeneOntologyCellularComponent | synaptonemal structure | 9.60e-04 | 46 | 88 | 3 | GO:0099086 | |
| GeneOntologyCellularComponent | npBAF complex | 1.54e-03 | 14 | 88 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 1.54e-03 | 14 | 88 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 2.02e-03 | 16 | 88 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.22e-03 | 317 | 88 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | meiotic spindle | 2.86e-03 | 19 | 88 | 2 | GO:0072687 | |
| GeneOntologyCellularComponent | nuclear matrix | 2.91e-03 | 140 | 88 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | axon cytoplasm | 2.97e-03 | 68 | 88 | 3 | GO:1904115 | |
| MousePheno | respiratory failure | 2.17e-05 | 165 | 72 | 7 | MP:0001953 | |
| MousePheno | decreased respiration | 2.63e-05 | 170 | 72 | 7 | MP:0014274 | |
| Domain | Ryanrecept_TM4-6 | 9.43e-08 | 3 | 86 | 3 | IPR009460 | |
| Domain | RyR | 9.43e-08 | 3 | 86 | 3 | PF02026 | |
| Domain | Ryanodine_rcpt | 9.43e-08 | 3 | 86 | 3 | IPR003032 | |
| Domain | RR_TM4-6 | 9.43e-08 | 3 | 86 | 3 | PF06459 | |
| Domain | Ryan_recept | 9.43e-08 | 3 | 86 | 3 | IPR013333 | |
| Domain | RIH_assoc | 1.87e-06 | 6 | 86 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 1.87e-06 | 6 | 86 | 3 | IPR013662 | |
| Domain | RIH_dom | 1.87e-06 | 6 | 86 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.87e-06 | 6 | 86 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.87e-06 | 6 | 86 | 3 | IPR015925 | |
| Domain | - | 1.87e-06 | 6 | 86 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.87e-06 | 6 | 86 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 1.87e-06 | 6 | 86 | 3 | PF08709 | |
| Domain | MIR | 1.11e-05 | 10 | 86 | 3 | PS50919 | |
| Domain | MIR | 1.11e-05 | 10 | 86 | 3 | PF02815 | |
| Domain | MIR | 1.11e-05 | 10 | 86 | 3 | SM00472 | |
| Domain | MIR_motif | 1.11e-05 | 10 | 86 | 3 | IPR016093 | |
| Domain | BAF250_C | 2.10e-05 | 2 | 86 | 2 | IPR033388 | |
| Domain | S-AdoMet_synt_M | 2.10e-05 | 2 | 86 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 2.10e-05 | 2 | 86 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 2.10e-05 | 2 | 86 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 2.10e-05 | 2 | 86 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 2.10e-05 | 2 | 86 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_N | 2.10e-05 | 2 | 86 | 2 | PF00438 | |
| Domain | S-AdoMet_synt_central | 2.10e-05 | 2 | 86 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 2.10e-05 | 2 | 86 | 2 | IPR022628 | |
| Domain | BAF250_C | 2.10e-05 | 2 | 86 | 2 | PF12031 | |
| Domain | BAF250/Osa | 2.10e-05 | 2 | 86 | 2 | IPR021906 | |
| Domain | S-AdoMet_synthetase | 2.10e-05 | 2 | 86 | 2 | IPR002133 | |
| Domain | ADOMET_SYNTHASE_1 | 2.10e-05 | 2 | 86 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 2.10e-05 | 2 | 86 | 2 | PS00377 | |
| Domain | SPRY | 5.06e-05 | 87 | 86 | 5 | SM00449 | |
| Domain | ConA-like_dom | 6.79e-05 | 219 | 86 | 7 | IPR013320 | |
| Domain | SPRY | 7.32e-05 | 94 | 86 | 5 | PF00622 | |
| Domain | SPRY_dom | 7.32e-05 | 94 | 86 | 5 | IPR003877 | |
| Domain | B30.2/SPRY | 7.70e-05 | 95 | 86 | 5 | IPR001870 | |
| Domain | B302_SPRY | 7.70e-05 | 95 | 86 | 5 | PS50188 | |
| Domain | TRAF-like | 1.78e-04 | 24 | 86 | 3 | IPR008974 | |
| Domain | MATH/TRAF_dom | 1.34e-03 | 12 | 86 | 2 | IPR002083 | |
| Domain | MATH | 1.34e-03 | 12 | 86 | 2 | PS50144 | |
| Domain | MATH | 1.34e-03 | 12 | 86 | 2 | SM00061 | |
| Domain | MATH | 1.34e-03 | 12 | 86 | 2 | PF00917 | |
| Domain | START | 1.58e-03 | 13 | 86 | 2 | SM00234 | |
| Domain | TIL_dom | 1.84e-03 | 14 | 86 | 2 | IPR002919 | |
| Domain | - | 1.84e-03 | 14 | 86 | 2 | 2.60.210.10 | |
| Domain | Ion_trans_dom | 1.90e-03 | 114 | 86 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.90e-03 | 114 | 86 | 4 | PF00520 | |
| Domain | START | 2.12e-03 | 15 | 86 | 2 | PF01852 | |
| Domain | Bbox_C | 2.12e-03 | 15 | 86 | 2 | IPR003649 | |
| Domain | - | 2.12e-03 | 15 | 86 | 2 | 1.10.150.60 | |
| Domain | BBC | 2.12e-03 | 15 | 86 | 2 | SM00502 | |
| Domain | BRIGHT | 2.12e-03 | 15 | 86 | 2 | SM00501 | |
| Domain | ARID_dom | 2.12e-03 | 15 | 86 | 2 | IPR001606 | |
| Domain | ARID | 2.12e-03 | 15 | 86 | 2 | PS51011 | |
| Domain | START_lipid-bd_dom | 2.12e-03 | 15 | 86 | 2 | IPR002913 | |
| Domain | ARID | 2.12e-03 | 15 | 86 | 2 | PF01388 | |
| Domain | START | 2.12e-03 | 15 | 86 | 2 | PS50848 | |
| Domain | - | 4.16e-03 | 21 | 86 | 2 | 3.30.230.10 | |
| Domain | - | 4.16e-03 | 21 | 86 | 2 | 1.10.720.30 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 4.56e-03 | 22 | 86 | 2 | IPR014721 | |
| Domain | SAP | 4.56e-03 | 22 | 86 | 2 | PF02037 | |
| Domain | SAP | 4.98e-03 | 23 | 86 | 2 | SM00513 | |
| Domain | - | 4.98e-03 | 23 | 86 | 2 | 3.30.530.20 | |
| Domain | START-like_dom | 4.98e-03 | 23 | 86 | 2 | IPR023393 | |
| Domain | SAP | 5.87e-03 | 25 | 86 | 2 | PS50800 | |
| Domain | SAP_dom | 5.87e-03 | 25 | 86 | 2 | IPR003034 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.22e-05 | 11 | 74 | 3 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 3.82e-05 | 13 | 74 | 3 | M39589 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.27e-04 | 19 | 74 | 3 | M47760 | |
| Pubmed | SOX6 RLF ACTR8 ARID1B TCERG1 HNRNPUL2 YBX1 RBM33 PURA PABPC4 LRP2 PSMD4 CHD7 RFC1 PFKP MBD6 ARID1A MEF2D DYNC1H1 LGALS3BP DCAF7 | 4.78e-11 | 1429 | 88 | 21 | 35140242 | |
| Pubmed | RLF ARID1B TCERG1 YBX1 RBM33 MAT2A PABPC4 CPNE1 CHD7 RFC1 ARID1A HNRNPD MEF2D DYNC1H1 HEXIM1 HNRNPU DCAF7 | 2.17e-09 | 1103 | 88 | 17 | 34189442 | |
| Pubmed | TPR ACTR8 HNRNPUL2 YBX1 PURA PABPC4 CPNE1 ARMCX3 HNRNPD HEXIM1 HNRNPU | 4.53e-09 | 390 | 88 | 11 | 17643375 | |
| Pubmed | 5.79e-09 | 55 | 88 | 6 | 31640799 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 18403125 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 7876312 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.57e-08 | 3 | 88 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.57e-08 | 3 | 88 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.57e-08 | 3 | 88 | 3 | 10473538 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.57e-08 | 3 | 88 | 3 | 9204703 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.57e-08 | 3 | 88 | 3 | 12213830 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 9242641 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 25239916 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 18643873 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 11159936 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.57e-08 | 3 | 88 | 3 | 4600883 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 7635066 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR ARID1B ZNHIT6 HNRNPUL2 YBX1 LEMD3 PABPC4 PACSIN3 TACC2 GPC5 ARID1A HNRNPD DYNC1H1 LGALS3BP HNRNPU DCAF7 | 3.03e-08 | 1155 | 88 | 16 | 20360068 |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 6.25e-08 | 4 | 88 | 3 | 23413940 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 9607712 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 23482488 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 18206662 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 9384575 | ||
| Pubmed | 1.16e-07 | 90 | 88 | 6 | 23151878 | ||
| Pubmed | 1.17e-07 | 46 | 88 | 5 | 20301533 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ARID1B TCERG1 YBX1 LEMD3 RBM33 PABPC4 CHD7 DGCR8 RFC1 ARID1A HNRNPD MEF2D HNRNPU | 1.22e-07 | 954 | 88 | 14 | 36373674 |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.56e-07 | 5 | 88 | 3 | 19011160 | |
| Pubmed | HNRNPUL2 YBX1 MAT2A PNO1 FADS2 CPNE1 PSMD4 HNRNPD LGALS3BP HNRNPU | 2.89e-07 | 464 | 88 | 10 | 32457219 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.11e-07 | 6 | 88 | 3 | 26025922 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 3.11e-07 | 6 | 88 | 3 | 14592808 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.11e-07 | 6 | 88 | 3 | 25966694 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 19009018 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.11e-07 | 6 | 88 | 3 | 16844763 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR TCERG1 YBX1 MAT2A PABPC4 PACSIN3 PNO1 TACC2 RFC1 PFKP ARMCX3 HNRNPD DYNC1H1 HEXIM1 LGALS3BP HNRNPU | 4.72e-07 | 1415 | 88 | 16 | 28515276 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | TCERG1 HNRNPUL2 YBX1 PURA PABPC4 PNO1 TACC2 DGCR8 RFC1 HNRNPD HNRNPU DCAF7 | 4.83e-07 | 759 | 88 | 12 | 35915203 |
| Pubmed | TPR HNRNPUL2 YBX1 PABPC4 PSMD4 PFKP HNRNPD LGALS3BP HNRNPU DCAF7 | 5.12e-07 | 494 | 88 | 10 | 26831064 | |
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 11860456 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 20962236 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR TCERG1 HNRNPUL2 YBX1 MAT2A PABPC4 PACSIN3 PNO1 RFC1 PFKP HNRNPD DYNC1H1 LGALS3BP HNRNPU DCAF7 | 5.77e-07 | 1257 | 88 | 15 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ZNHIT6 TCERG1 YBX1 MAT2A NT5C3A PABPC4 PSMD4 RFC1 PFKP PIPSL HNRNPD DYNC1H1 LGALS3BP HNRNPU DCAF7 | 5.77e-07 | 1257 | 88 | 15 | 37317656 |
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 8.69e-07 | 8 | 88 | 3 | 19033399 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | ANGPTL2 HNRNPUL2 YBX1 PABPC4 PACSIN3 HNRNPD DYNC1H1 HNRNPU DCAF7 | 1.19e-06 | 418 | 88 | 9 | 32552912 |
| Pubmed | 1.36e-06 | 425 | 88 | 9 | 21081503 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RLF TPR TCERG1 HNRNPUL2 YBX1 MAT2A PNO1 PSMD4 CHD7 RFC1 PFKP ARID1A HNRNPD DYNC1H1 HNRNPU | 1.44e-06 | 1353 | 88 | 15 | 29467282 |
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 15282343 | ||
| Pubmed | 2.12e-06 | 36 | 88 | 4 | 17289661 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.64e-06 | 38 | 88 | 4 | 30786075 | |
| Pubmed | TPR YBX1 MAT2A PABPC4 PNO1 PSMD4 RFC1 PFKP ARID1A MEF2D MED13 DYNC1H1 HEXIM1 HNRNPU | 2.92e-06 | 1247 | 88 | 14 | 27684187 | |
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 3.26e-06 | 40 | 88 | 4 | 23825951 | |
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 19095005 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FNTA HNRNPUL2 YBX1 MAT2A NAP1L5 PABPC4 PNO1 LAGE3 PSMD4 PFKP ARMCX3 HNRNPD DYNC1H1 HEXIM1 HNRNPU | 3.51e-06 | 1455 | 88 | 15 | 22863883 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR ZNHIT6 TCERG1 HNRNPUL2 YBX1 MAT1A MAT2A PABPC4 PFKP HNRNPD DYNC1H1 HNRNPU | 4.87e-06 | 949 | 88 | 12 | 36574265 |
| Pubmed | SP3 TCERG1 LEMD3 RBM33 PURA PABPC4 PACSIN3 PNO1 LSM11 CHD7 DGCR8 PFKP MED13 HEXIM1 DCAF7 | 4.96e-06 | 1497 | 88 | 15 | 31527615 | |
| Pubmed | 5.56e-06 | 268 | 88 | 7 | 33640491 | ||
| Pubmed | DCDC2 HNRNPUL2 YBX1 MAT2A PABPC4 PFKP ARID1A HNRNPD DYNC1H1 LGALS3BP HNRNPU | 5.91e-06 | 803 | 88 | 11 | 36517590 | |
| Pubmed | RLF ZNHIT6 YBX1 MAT2A PURA PABPC4 PNO1 PSMD4 RFC1 HNRNPD HNRNPU DCAF7 | 6.14e-06 | 971 | 88 | 12 | 33306668 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR TCERG1 FNTA YBX1 MAT2A PABPC4 PEX19 RFC1 PFKP HNRNPD DYNC1H1 HNRNPU DCAF7 | 6.31e-06 | 1149 | 88 | 13 | 35446349 |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 11447232 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27699813 | ||
| Pubmed | Purification of two isoforms of hnRNP-U and characterization of their nucleic acid binding activity. | 6.33e-06 | 2 | 88 | 2 | 8068679 | |
| Pubmed | AUF-1 and YB-1 are critical determinants of β-globin mRNA expression in erythroid cells. | 6.33e-06 | 2 | 88 | 2 | 22134169 | |
| Pubmed | Role of FOXO3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma. | 6.33e-06 | 2 | 88 | 2 | 32234881 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9852958 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9489997 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22318685 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 17259277 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 6.33e-06 | 2 | 88 | 2 | 12640042 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 6.33e-06 | 2 | 88 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 6.33e-06 | 2 | 88 | 2 | 26009179 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 32899693 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 14592949 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 8898078 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 6.33e-06 | 2 | 88 | 2 | 37611161 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 32791957 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29749642 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 14550562 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9799464 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 6.33e-06 | 2 | 88 | 2 | 28967863 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 31234428 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 6.33e-06 | 2 | 88 | 2 | 15033925 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29448301 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 6.33e-06 | 2 | 88 | 2 | 17118445 | |
| Pubmed | SIRT2-PFKP interaction dysregulates phagocytosis in macrophages with acute ethanol-exposure. | 6.33e-06 | 2 | 88 | 2 | 36865524 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 6.33e-06 | 2 | 88 | 2 | 11500519 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 31727006 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 34386776 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 23202128 | ||
| Pubmed | Spinal sirtuin 2 attenuates bone cancer pain by deacetylating FoxO3a. | 6.33e-06 | 2 | 88 | 2 | 38513990 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 33890484 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 6.33e-06 | 2 | 88 | 2 | 21531043 | |
| Pubmed | Genetic investigation of FOXO3A requires special attention due to sequence homology with FOXO3B. | 6.33e-06 | 2 | 88 | 2 | 22588664 | |
| Interaction | SOX2 interactions | SOX6 RLF ARID1B HNRNPUL2 YBX1 NT5C3A PABPC4 PNO1 FADS2 CHD7 DGCR8 RFC1 PFKP ST7L ARID1A HNRNPD MEF2D RYR1 LGALS3BP HNRNPU DCAF7 | 5.84e-07 | 1422 | 88 | 21 | int:SOX2 |
| Interaction | MECOM interactions | SOX6 TPR ARID1B HNRNPUL2 RFC1 PFKP TRIM37 DYNC1H1 LGALS3BP HNRNPU | 3.64e-06 | 358 | 88 | 10 | int:MECOM |
| Interaction | CEBPA interactions | RLF ARID1B TCERG1 HNRNPUL2 YBX1 RBM33 MAT2A PABPC4 CPNE1 CHD7 RFC1 ARID1A HNRNPD MEF2D DYNC1H1 HEXIM1 HNRNPU DCAF7 | 5.89e-06 | 1245 | 88 | 18 | int:CEBPA |
| Interaction | ERG interactions | 5.96e-06 | 223 | 88 | 8 | int:ERG | |
| Interaction | PRMT5 interactions | ARID1B ZNHIT6 TCERG1 LSM11 SSTR1 ARID1A HNRNPD MEF2D DYNC1H1 HEXIM1 HNRNPU | 6.40e-06 | 471 | 88 | 11 | int:PRMT5 |
| Interaction | MKRN1 interactions | 7.90e-06 | 165 | 88 | 7 | int:MKRN1 | |
| Interaction | GCH1 interactions | 8.15e-06 | 63 | 88 | 5 | int:GCH1 | |
| Interaction | POU5F1 interactions | TPR GARIN3 ARID1B TCERG1 YBX1 LEMD3 PURA CHD7 RFC1 ARID1A DYNC1H1 HNRNPU | 8.65e-06 | 584 | 88 | 12 | int:POU5F1 |
| Interaction | H2AC4 interactions | ACTR8 SIRT2 YBX1 PURA PABPC4 PSMD4 RFC1 ARID1A TRIM37 HNRNPD HEXIM1 | 1.25e-05 | 506 | 88 | 11 | int:H2AC4 |
| Interaction | INS interactions | HNRNPUL2 YBX1 MAT2A LRP2 PNO1 FADS2 CPNE1 PSMD4 HNRNPD LGALS3BP HNRNPU | 1.59e-05 | 519 | 88 | 11 | int:INS |
| Interaction | HNF1B interactions | 1.98e-05 | 190 | 88 | 7 | int:HNF1B | |
| Interaction | AR interactions | TPR ARID1B MLH3 HNRNPUL2 RBM33 FADS2 CHD7 ARID1A HNRNPD MEF2D MED13 DYNC1H1 HEXIM1 HNRNPU DCAF7 | 2.36e-05 | 992 | 88 | 15 | int:AR |
| Interaction | FUS interactions | TCERG1 HNRNPUL2 YBX1 MAT2A PABPC4 DGCR8 PFKP ARID1A HNRNPD MEF2D DYNC1H1 HEXIM1 HNRNPU | 2.39e-05 | 757 | 88 | 13 | int:FUS |
| Interaction | PDCD6 interactions | 3.12e-05 | 204 | 88 | 7 | int:PDCD6 | |
| Interaction | RIOK1 interactions | AGBL4 SIRT2 HNRNPUL2 YBX1 PURA PABPC4 PNO1 PFKP HNRNPD DYNC1H1 HNRNPU | 3.30e-05 | 562 | 88 | 11 | int:RIOK1 |
| Interaction | IL7R interactions | 3.57e-05 | 141 | 88 | 6 | int:IL7R | |
| Interaction | ACTC1 interactions | TPR FBXO40 ARID1B TCERG1 YBX1 RBM33 ARID1A TRIM37 HNRNPD DYNC1H1 HEXIM1 DCAF7 | 4.73e-05 | 694 | 88 | 12 | int:ACTC1 |
| Interaction | SP7 interactions | 5.52e-05 | 304 | 88 | 8 | int:SP7 | |
| Interaction | FOXG1 interactions | 6.02e-05 | 95 | 88 | 5 | int:FOXG1 | |
| Interaction | ACTB interactions | FBXO40 ERBB2 ACTR8 ARID1B YBX1 LEMD3 PABPC4 CPNE1 ARID1A TRIM37 HNRNPD DYNC1H1 HEXIM1 LGALS3BP HNRNPU | 6.46e-05 | 1083 | 88 | 15 | int:ACTB |
| Interaction | SOX6 interactions | 6.50e-05 | 157 | 88 | 6 | int:SOX6 | |
| Interaction | BRCA1 interactions | FOXO3 TRIM45 TPR FNTA HNRNPUL2 YBX1 PABPC4 PSMD4 RFC1 PFKP ARID1A HNRNPD DYNC1H1 LGALS3BP HNRNPU DCAF7 | 9.01e-05 | 1249 | 88 | 16 | int:BRCA1 |
| Interaction | SMC5 interactions | TPR ARID1B TCERG1 YBX1 LEMD3 RBM33 PABPC4 CHD7 DGCR8 RFC1 ARID1A HNRNPD MEF2D HNRNPU | 1.04e-04 | 1000 | 88 | 14 | int:SMC5 |
| Interaction | NUBP2 interactions | 1.08e-04 | 172 | 88 | 6 | int:NUBP2 | |
| Interaction | CHD3 interactions | SOX6 TPR TCERG1 HNRNPUL2 YBX1 PABPC4 PNO1 RFC1 ARID1A HNRNPD HEXIM1 HNRNPU | 1.08e-04 | 757 | 88 | 12 | int:CHD3 |
| Interaction | PAX8 interactions | 1.26e-04 | 111 | 88 | 5 | int:PAX8 | |
| Interaction | BTRC interactions | FOXO3 TPR ERBB2 SIRT2 HNRNPUL2 YBX1 PABPC4 PSMD4 SH3BP5L ARID1A HNRNPD HNRNPU | 1.35e-04 | 775 | 88 | 12 | int:BTRC |
| Interaction | HNRNPU interactions | TPR TCERG1 YBX1 LEMD3 PABPC4 PNO1 DGCR8 RFC1 TRIM37 HNRNPD DYNC1H1 HEXIM1 LGALS3BP HNRNPU | 1.50e-04 | 1035 | 88 | 14 | int:HNRNPU |
| Interaction | TBXT interactions | 1.55e-04 | 116 | 88 | 5 | int:TBXT | |
| Interaction | FZR1 interactions | RLF ERBB2 SIRT2 ZNHIT6 HNRNPUL2 YBX1 MAT2A PURA PABPC4 PNO1 PSMD4 RFC1 HNRNPD HNRNPU DCAF7 | 1.56e-04 | 1172 | 88 | 15 | int:FZR1 |
| Interaction | BAP1 interactions | TPR TCERG1 FNTA YBX1 MAT2A NAP1L5 PABPC4 PEX19 PSMD4 RFC1 PFKP MBD6 HNRNPD DYNC1H1 HNRNPU DCAF7 | 1.62e-04 | 1314 | 88 | 16 | int:BAP1 |
| Interaction | CTCF interactions | 1.83e-04 | 461 | 88 | 9 | int:CTCF | |
| Interaction | SURF2 interactions | 1.88e-04 | 65 | 88 | 4 | int:SURF2 | |
| Interaction | RIN3 interactions | ANGPTL2 HNRNPUL2 YBX1 PABPC4 PACSIN3 HNRNPD DYNC1H1 HNRNPU DCAF7 | 1.89e-04 | 463 | 88 | 9 | int:RIN3 |
| Interaction | GAPDH interactions | ERBB2 FKBP6 YBX1 MAT2A PABPC4 RFC1 TRIM37 HNRNPD RYR1 HEXIM1 HNRNPU | 1.94e-04 | 686 | 88 | 11 | int:GAPDH |
| Interaction | LARP1 interactions | 1.95e-04 | 465 | 88 | 9 | int:LARP1 | |
| Interaction | PABPN1 interactions | 1.96e-04 | 192 | 88 | 6 | int:PABPN1 | |
| Interaction | PAX7 interactions | 2.12e-04 | 124 | 88 | 5 | int:PAX7 | |
| Interaction | PEX10 interactions | 2.44e-04 | 28 | 88 | 3 | int:PEX10 | |
| Interaction | CUL2 interactions | ARID1B YBX1 MAT2A PABPC4 LAGE3 PSMD4 ARID1A HNRNPD LGALS3BP HNRNPU | 2.52e-04 | 591 | 88 | 10 | int:CUL2 |
| Interaction | PAX9 interactions | 2.64e-04 | 130 | 88 | 5 | int:PAX9 | |
| Interaction | ZBTB7A interactions | 2.73e-04 | 131 | 88 | 5 | int:ZBTB7A | |
| Interaction | FOXO3B interactions | 2.80e-04 | 6 | 88 | 2 | int:FOXO3B | |
| Interaction | SMAD2 interactions | 2.80e-04 | 385 | 88 | 8 | int:SMAD2 | |
| Interaction | MAP2K1 interactions | 2.97e-04 | 293 | 88 | 7 | int:MAP2K1 | |
| Interaction | PRC1 interactions | TPR ACTR8 TCERG1 HNRNPUL2 YBX1 MAT2A PABPC4 TACC2 ARID1A TRIM37 HNRNPD DYNC1H1 HNRNPU | 2.97e-04 | 973 | 88 | 13 | int:PRC1 |
| Interaction | FN1 interactions | COL2A1 MEP1B TPR TCERG1 YBX1 PABPC4 CPNE1 PFKP HNRNPD DYNC1H1 LGALS3BP HNRNPU | 3.09e-04 | 848 | 88 | 12 | int:FN1 |
| Interaction | RB1 interactions | 3.27e-04 | 394 | 88 | 8 | int:RB1 | |
| Interaction | SNRPA1 interactions | 3.42e-04 | 300 | 88 | 7 | int:SNRPA1 | |
| Interaction | RNF169 interactions | 3.43e-04 | 76 | 88 | 4 | int:RNF169 | |
| Interaction | MEPCE interactions | ERBB2 HNRNPUL2 YBX1 MAT2A PURA PABPC4 PSMD4 PIPSL HNRNPD DYNC1H1 HEXIM1 HNRNPU | 3.47e-04 | 859 | 88 | 12 | int:MEPCE |
| Interaction | POLE interactions | 3.59e-04 | 139 | 88 | 5 | int:POLE | |
| Interaction | IFIT3 interactions | 4.17e-04 | 80 | 88 | 4 | int:IFIT3 | |
| Interaction | SNRPB interactions | 4.25e-04 | 517 | 88 | 9 | int:SNRPB | |
| Interaction | OASL interactions | 4.37e-04 | 223 | 88 | 6 | int:OASL | |
| Interaction | PIN4 interactions | 4.37e-04 | 81 | 88 | 4 | int:PIN4 | |
| Interaction | PRKACA interactions | 4.37e-04 | 519 | 88 | 9 | int:PRKACA | |
| Interaction | NCOA3 interactions | 4.47e-04 | 224 | 88 | 6 | int:NCOA3 | |
| Interaction | ELF5 interactions | 4.65e-04 | 147 | 88 | 5 | int:ELF5 | |
| Interaction | ZC3H3 interactions | 4.69e-04 | 226 | 88 | 6 | int:ZC3H3 | |
| Interaction | SRA1 interactions | 4.79e-04 | 83 | 88 | 4 | int:SRA1 | |
| Interaction | KLF3 interactions | 4.91e-04 | 228 | 88 | 6 | int:KLF3 | |
| Interaction | NEDD4L interactions | 5.04e-04 | 320 | 88 | 7 | int:NEDD4L | |
| Interaction | ILF3 interactions | TPR ERBB2 HNRNPUL2 YBX1 LEMD3 PABPC4 DGCR8 MBD6 TRIM37 HNRNPD HEXIM1 HNRNPU | 5.07e-04 | 896 | 88 | 12 | int:ILF3 |
| Interaction | IRF4 interactions | 5.25e-04 | 85 | 88 | 4 | int:IRF4 | |
| Interaction | C9orf72 interactions | ZNHIT6 TCERG1 YBX1 MAT2A NT5C3A PABPC4 PSMD4 RFC1 PFKP PIPSL HNRNPD DYNC1H1 LGALS3BP HNRNPU DCAF7 | 5.51e-04 | 1319 | 88 | 15 | int:C9orf72 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.84e-08 | 3 | 62 | 3 | 287 | |
| GeneFamily | AT-rich interaction domain containing | 1.18e-03 | 15 | 62 | 2 | 418 | |
| GeneFamily | StAR related lipid transfer domain containing | 1.18e-03 | 15 | 62 | 2 | 759 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN | 5.10e-06 | 200 | 88 | 7 | M5234 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 88 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 88 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 88 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.88e-06 | 186 | 88 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.88e-06 | 186 | 88 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.33e-06 | 193 | 88 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 194 | 88 | 6 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-06 | 195 | 88 | 6 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.55e-06 | 196 | 88 | 6 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 178 | 88 | 5 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 186 | 88 | 5 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.48e-05 | 187 | 88 | 5 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-epi-tip_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.57e-05 | 188 | 88 | 5 | eefd2930833d216efbd72f67541bb2d9e7d47f3b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 190 | 88 | 5 | 11f32f46661e44770782b8ec13c00028e1dfc3cd | |
| ToppCell | AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.76e-05 | 190 | 88 | 5 | 46dfab02c1b4a403b7efc871707b6a189eefd4c4 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 190 | 88 | 5 | 20f4f6fe09345878484086047061d6f900f9d476 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.85e-05 | 191 | 88 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.85e-05 | 191 | 88 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.95e-05 | 192 | 88 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.95e-05 | 192 | 88 | 5 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.05e-05 | 193 | 88 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.05e-05 | 193 | 88 | 5 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.15e-05 | 194 | 88 | 5 | 920955e775617d6156c5ee8b90d2cecd01a70e12 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.15e-05 | 194 | 88 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.25e-05 | 195 | 88 | 5 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.25e-05 | 195 | 88 | 5 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.36e-05 | 196 | 88 | 5 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.36e-05 | 196 | 88 | 5 | 8faac7fbdee3a9297023c3151ef1751605413e44 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.46e-05 | 197 | 88 | 5 | d9a5b6171867de21d4ef12aa5a802fb4de9e0c00 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.46e-05 | 197 | 88 | 5 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.46e-05 | 197 | 88 | 5 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 197 | 88 | 5 | d2a4d7e92e91bcc47a7657da2e5c8a3ad7eb08ad | |
| ToppCell | distal-1-Epithelial-Alveolar_Epithelial_Type_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.57e-05 | 198 | 88 | 5 | ce9d6b2a93c7b304414ce1b8b1a09562cf581278 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | distal-1-Epithelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.68e-05 | 199 | 88 | 5 | 9086dbb60863c3da2cc5d0a310f28596a01c52ca | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.68e-05 | 199 | 88 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.68e-05 | 199 | 88 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.79e-05 | 200 | 88 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Cerebellum-Neuronal-Excitatory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.21e-04 | 128 | 88 | 4 | c30ba14320e9b98c9af9e4cd5a8c55380bb9ffa9 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-2|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.36e-04 | 132 | 88 | 4 | a8e7e7f38af095d63e221bcc06a1e5147bb6e467 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.57e-04 | 137 | 88 | 4 | 2a5d2a99a2c532480d00b80a4885514a8a5c80fa | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.66e-04 | 139 | 88 | 4 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.65e-04 | 157 | 88 | 4 | 0551442ae14685d8fe5729e3960c6324b1e05e4d | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.65e-04 | 157 | 88 | 4 | 803af734d7f775d294391e2b84e472a732e18cef | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.65e-04 | 157 | 88 | 4 | 9aa5304a9704da6dd4eda7d6940494b00e38b2e8 | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.78e-04 | 159 | 88 | 4 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 2.92e-04 | 161 | 88 | 4 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 162 | 88 | 4 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 162 | 88 | 4 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-04 | 164 | 88 | 4 | d6f71d804bb65301c02ea4e6673e20688b5fcd5b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.27e-04 | 166 | 88 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 167 | 88 | 4 | 73fdf4b81a45ec686d2929eaf641b434f70b7898 | |
| ToppCell | facs-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 167 | 88 | 4 | c4157fb31b44fe7c44be4215dda8ae2d37cf49a8 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.43e-04 | 168 | 88 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.50e-04 | 169 | 88 | 4 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-04 | 171 | 88 | 4 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-04 | 171 | 88 | 4 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 175 | 88 | 4 | 6bb8fc2959583644f16b22e906af91af62a3a633 | |
| ToppCell | RSV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 4.00e-04 | 175 | 88 | 4 | c47440c0b0513e67fe13b85f10dd8a8d42d0e9a3 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 175 | 88 | 4 | 8902c38067f025b094ca9c28c449c32a66eded1c | |
| ToppCell | RSV-Healthy-2|RSV / Virus stimulation, Condition and Cluster | 4.00e-04 | 175 | 88 | 4 | 0e97189585b7afaf3bd622c3ef10c86412393829 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.00e-04 | 175 | 88 | 4 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 176 | 88 | 4 | 3027d34fd663c8a08544d469183dc45138916749 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 177 | 88 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-04 | 177 | 88 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-04 | 178 | 88 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-04 | 179 | 88 | 4 | 466da2bc3bfc534ffe111c8c28ece7a3cfa08051 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-04 | 179 | 88 | 4 | f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-04 | 180 | 88 | 4 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 4.45e-04 | 180 | 88 | 4 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-04 | 181 | 88 | 4 | 1037051eb82313c13346617b33f3c4c648181c4d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 181 | 88 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 4.63e-04 | 182 | 88 | 4 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.73e-04 | 183 | 88 | 4 | 9a2cd63af5f492d46ce80ca1536312e8ac0e7df4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.73e-04 | 183 | 88 | 4 | 8c8ce5a0d5535bef58ac10b7eb726f9c50af2ed8 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 184 | 88 | 4 | 978135173891c83470370a42b2801e09eb740320 | |
| ToppCell | Cerebellum-Macroglia|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.83e-04 | 184 | 88 | 4 | 91b047a01d2cad231308279ca37fa699630f7864 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.83e-04 | 184 | 88 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 184 | 88 | 4 | 04bd8ab5808fcfa923aa4d0edf6a7f88b7980122 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 184 | 88 | 4 | f58922cf593f4b739f2713ef88a2ca3014f927e9 | |
| ToppCell | Hippocampus-Macroglia|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.83e-04 | 184 | 88 | 4 | a1d039ddf1e2a87b870f3ce6d139be56090349df | |
| ToppCell | megakaryocytic|World / Lineage and Cell class | 4.83e-04 | 184 | 88 | 4 | b1c630ca2189d9d49402a5621b57618976fbea5c | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 184 | 88 | 4 | e727bf110cb6a91a655c1865b0e93e51e2f9dda3 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 185 | 88 | 4 | 6938ac3cab536cf8a474eba441ce6dcdfcc43b53 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 4.93e-04 | 185 | 88 | 4 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 185 | 88 | 4 | 0e7351cd6d6e6e8c29573042e168da50ee496cfc | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.03e-04 | 186 | 88 | 4 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 186 | 88 | 4 | f14722ecc832794dc267bf3f9b8a13274c3addc1 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-04 | 186 | 88 | 4 | 4bb54043f944a979db91bde9a86dd66f498c7658 | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 5.03e-04 | 186 | 88 | 4 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| Drug | 2-hydroxycarbazole | 5.39e-08 | 3 | 87 | 3 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 5.39e-08 | 3 | 87 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 5.39e-08 | 3 | 87 | 3 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 5.39e-08 | 3 | 87 | 3 | CID005748312 | |
| Drug | 8N3-cADPR | 5.39e-08 | 3 | 87 | 3 | CID000127713 | |
| Drug | aminodantrolene | 5.39e-08 | 3 | 87 | 3 | CID009570289 | |
| Drug | PCB74 | 2.15e-07 | 4 | 87 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 2.15e-07 | 4 | 87 | 3 | CID006444275 | |
| Drug | SC 38249 | 2.15e-07 | 4 | 87 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 2.15e-07 | 4 | 87 | 3 | CID000035682 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.87e-07 | 182 | 87 | 8 | 3887_DN | |
| Drug | europium | 1.03e-06 | 87 | 87 | 6 | CID000023981 | |
| Drug | MBED | 1.07e-06 | 6 | 87 | 3 | CID000129958 | |
| Drug | chloro-m-cresol | 1.07e-06 | 6 | 87 | 3 | CID000012008 | |
| Drug | AC1O528X | 1.07e-06 | 6 | 87 | 3 | CID006475857 | |
| Drug | NSC114784 | 1.07e-06 | 6 | 87 | 3 | CID000419425 | |
| Drug | Azumoleno | 1.87e-06 | 7 | 87 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 1.87e-06 | 7 | 87 | 3 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.87e-06 | 7 | 87 | 3 | CID009547999 | |
| Drug | nilvadipine | 3.36e-06 | 60 | 87 | 5 | CID000004494 | |
| Drug | 2,4-xylidinothiazoline | 5.05e-06 | 30 | 87 | 4 | CID000099296 | |
| Drug | M-HN | 5.78e-06 | 31 | 87 | 4 | CID000015450 | |
| Drug | PCB 95 | 6.34e-06 | 10 | 87 | 3 | CID000038012 | |
| Drug | AC1L2AC7 | 6.72e-06 | 69 | 87 | 5 | CID000068733 | |
| Drug | CNS 1145 | 7.48e-06 | 33 | 87 | 4 | CID000190902 | |
| Drug | IHC-64 | 7.48e-06 | 33 | 87 | 4 | CID000162753 | |
| Drug | PCB 66 | 8.70e-06 | 11 | 87 | 3 | CID000036185 | |
| Drug | R 478 | 8.70e-06 | 11 | 87 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 8.70e-06 | 11 | 87 | 3 | CID003081323 | |
| Drug | Ryanodine | 1.16e-05 | 12 | 87 | 3 | ctd:D012433 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.44e-05 | 2 | 87 | 2 | ctd:C005147 | |
| Drug | didodecyl selenide | 1.44e-05 | 2 | 87 | 2 | CID000079891 | |
| Drug | 2-amino-4-methylthio-3-butenoic acid | 1.44e-05 | 2 | 87 | 2 | ctd:C083253 | |
| Drug | NAADP | 1.48e-05 | 39 | 87 | 4 | CID000123952 | |
| Drug | cADPR | 1.57e-05 | 82 | 87 | 5 | CID000123847 | |
| Drug | FPL 64176 | 2.37e-05 | 15 | 87 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 2.37e-05 | 15 | 87 | 3 | CID000125015 | |
| Drug | AC1NE2TZ | 2.40e-05 | 44 | 87 | 4 | CID004635680 | |
| Drug | 4,4'-dithiodipyridine | 2.63e-05 | 45 | 87 | 4 | CID000075846 | |
| Drug | kazinol B | 3.53e-05 | 17 | 87 | 3 | CID000480869 | |
| Drug | isotetrandrine | 3.55e-05 | 97 | 87 | 5 | CID000005422 | |
| Drug | Trp-Trp | 3.70e-05 | 49 | 87 | 4 | CID000088656 | |
| Drug | isradipine | 4.11e-05 | 100 | 87 | 5 | CID000003784 | |
| Drug | methylcoumarin | 4.22e-05 | 18 | 87 | 3 | CID000007092 | |
| Drug | L-2-amino-4-methylthio-cis-but-3-enoic acid | 4.32e-05 | 3 | 87 | 2 | CID006439623 | |
| Drug | tryptamide | 4.32e-05 | 3 | 87 | 2 | CID000065768 | |
| Drug | AC1O5FKL | 4.32e-05 | 3 | 87 | 2 | CID006433101 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 4.32e-05 | 3 | 87 | 2 | CID000080262 | |
| Drug | benzylphosphate | 4.32e-05 | 3 | 87 | 2 | CID000074359 | |
| Drug | flubendiamide | 4.32e-05 | 3 | 87 | 2 | CID011193251 | |
| Drug | AC1L380G | 5.00e-05 | 19 | 87 | 3 | CID000084698 | |
| Drug | AC1MW7VF | 5.00e-05 | 19 | 87 | 3 | CID000414699 | |
| Drug | Cinildipine | 6.28e-05 | 56 | 87 | 4 | CID000002752 | |
| Drug | indo-1/AM | 6.82e-05 | 21 | 87 | 3 | CID000123918 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.54e-05 | 184 | 87 | 6 | 2321_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 7.77e-05 | 185 | 87 | 6 | 1114_DN | |
| Drug | O-Su | 8.24e-05 | 60 | 87 | 4 | CID000447970 | |
| Drug | A-30 | 8.62e-05 | 4 | 87 | 2 | CID003028528 | |
| Drug | NSC-187732 | 8.62e-05 | 4 | 87 | 2 | CID000302526 | |
| Drug | vinthionine | 8.62e-05 | 4 | 87 | 2 | CID000055145 | |
| Drug | Bastadin 10 | 8.62e-05 | 4 | 87 | 2 | CID009589366 | |
| Drug | seleno-DL-ethionine | 8.62e-05 | 4 | 87 | 2 | CID000145924 | |
| Drug | IAA-94 | 8.79e-05 | 61 | 87 | 4 | CID000003667 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.53e-05 | 192 | 87 | 6 | 6435_DN | |
| Drug | lercanidipine | 9.97e-05 | 63 | 87 | 4 | CID000065866 | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 2708_DN | |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; HL60; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 1315_UP | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 6079_UP | |
| Drug | Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 6312_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; PC3; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 5844_UP | |
| Drug | T0702 | 1.17e-04 | 25 | 87 | 3 | CID000005908 | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.19e-04 | 200 | 87 | 6 | 6676_DN | |
| Drug | bepridil | 1.23e-04 | 126 | 87 | 5 | CID000002351 | |
| Drug | gallopamil | 1.27e-04 | 67 | 87 | 4 | CID000001234 | |
| Drug | 4-ethylguaiacol | 1.43e-04 | 5 | 87 | 2 | CID000062465 | |
| Drug | 3-butenoic acid | 1.43e-04 | 5 | 87 | 2 | CID000032743 | |
| Drug | AC1NSBNC | 1.43e-04 | 5 | 87 | 2 | CID005357915 | |
| Drug | A 68930 | 1.43e-04 | 5 | 87 | 2 | ctd:C065380 | |
| Drug | adenine | 1.44e-04 | 510 | 87 | 9 | CID000000190 | |
| Drug | NaMN | 1.50e-04 | 70 | 87 | 4 | CID000000941 | |
| Drug | AC1L1D8L | 1.59e-04 | 71 | 87 | 4 | CID000002241 | |
| Drug | silver chloride | 1.65e-04 | 28 | 87 | 3 | CID000024561 | |
| Drug | AC1L1IZ2 | 1.66e-04 | 304 | 87 | 7 | CID000004795 | |
| Drug | CAS 298-57-7 | 1.77e-04 | 73 | 87 | 4 | CID000002761 | |
| Drug | ethosuximide | 1.87e-04 | 74 | 87 | 4 | CID000003291 | |
| Drug | LOPAC | 2.03e-04 | 30 | 87 | 3 | CID000062696 | |
| Drug | S-Adenosylmethionine | 2.14e-04 | 6 | 87 | 2 | DB00118 | |
| Drug | 2alpha-propoxy-1alpha,25-dihydroxyvitamin D3 | 2.14e-04 | 6 | 87 | 2 | CID010062706 | |
| Drug | NSC692750 | 2.14e-04 | 6 | 87 | 2 | CID000078910 | |
| Drug | AC1Q7BER | 2.14e-04 | 6 | 87 | 2 | CID000005702 | |
| Drug | 1zp8 | 2.18e-04 | 77 | 87 | 4 | CID004369521 | |
| Drug | nisoldipine | 2.29e-04 | 78 | 87 | 4 | CID000004499 | |
| Drug | Dantrolene-13C3 | 2.37e-04 | 145 | 87 | 5 | CID000002951 | |
| Drug | nicardipine | 2.37e-04 | 145 | 87 | 5 | CID000004473 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.40e-04 | 79 | 87 | 4 | CID005287890 | |
| Drug | M3/M4 | 2.47e-04 | 32 | 87 | 3 | CID000486507 | |
| Drug | monomethyl phthalate | COL2A1 SOX6 FOXO3 SP3 ERBB2 YBX1 MAT2A PURA CHD7 SSTR1 ARID1A MEF2D | 2.76e-04 | 957 | 87 | 12 | ctd:C517284 |
| Drug | mag-indo-1 | 2.99e-04 | 7 | 87 | 2 | CID000131881 | |
| Drug | 5'-S-isobutylthioadenosine | 2.99e-04 | 7 | 87 | 2 | CID000123674 | |
| Drug | CHEBI:564108 | 2.99e-04 | 7 | 87 | 2 | CID006400637 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.31e-08 | 3 | 85 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.31e-08 | 3 | 85 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.81e-08 | 195 | 85 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | dermoid cyst of ovary (implicated_via_orthology) | 8.20e-06 | 2 | 85 | 2 | DOID:5117 (implicated_via_orthology) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.02e-05 | 15 | 85 | 3 | DOID:3146 (implicated_via_orthology) | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.92e-05 | 23 | 85 | 3 | C0018784 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 8.15e-05 | 5 | 85 | 2 | C3281201 | |
| Disease | 1-stearoyl-GPC (18:0) measurement | 1.22e-04 | 6 | 85 | 2 | EFO_0800217 | |
| Disease | asthma, type 2 diabetes mellitus | 2.27e-04 | 8 | 85 | 2 | MONDO_0004979, MONDO_0005148 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.27e-04 | 41 | 85 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.27e-04 | 41 | 85 | 3 | C0858252 | |
| Disease | hippocampal CA1 volume | 3.63e-04 | 48 | 85 | 3 | EFO_0009394 | |
| Disease | neuroblastoma (is_implicated_in) | 3.64e-04 | 10 | 85 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Sensory hearing loss | 4.44e-04 | 11 | 85 | 2 | C1691779 | |
| Disease | lysophosphatidylcholine 20:2 measurement | 4.44e-04 | 11 | 85 | 2 | EFO_0021458 | |
| Disease | metabolite measurement, body weight gain | 5.31e-04 | 12 | 85 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | Coffin-Siris syndrome | 6.27e-04 | 13 | 85 | 2 | C0265338 | |
| Disease | cognitive behavioural therapy | 6.35e-04 | 58 | 85 | 3 | EFO_0007820 | |
| Disease | total lipids in medium HDL measurement | 6.35e-04 | 58 | 85 | 3 | EFO_0022310 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.98e-04 | 148 | 85 | 4 | C0279702 | |
| Disease | Microcephaly | 9.67e-04 | 67 | 85 | 3 | C0025958 | |
| Disease | Craniofacial Abnormalities | 1.09e-03 | 156 | 85 | 4 | C0376634 | |
| Disease | triglycerides to total lipids in small HDL percentage | 1.19e-03 | 72 | 85 | 3 | EFO_0022336 | |
| Disease | phospholipids in large HDL measurement | 1.24e-03 | 73 | 85 | 3 | EFO_0022190 | |
| Disease | cortical thickness | FOXO3 AGBL4 ARID1B GALK2 ARRDC4 FADS2 TACC2 CHD7 MBD6 HNRNPD | 1.35e-03 | 1113 | 85 | 10 | EFO_0004840 |
| Disease | blood aluminium measurement | 1.51e-03 | 20 | 85 | 2 | EFO_0007575 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.62e-03 | 80 | 85 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | gestational age, birth measurement | 1.66e-03 | 21 | 85 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | Nonsyndromic Deafness | 1.67e-03 | 81 | 85 | 3 | C3711374 | |
| Disease | hippocampal volume | 1.70e-03 | 297 | 85 | 5 | EFO_0005035 | |
| Disease | Epilepsy, Cryptogenic | 1.73e-03 | 82 | 85 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.73e-03 | 82 | 85 | 3 | C0751111 | |
| Disease | Aura | 1.73e-03 | 82 | 85 | 3 | C0236018 | |
| Disease | Nasopharyngeal carcinoma | 1.82e-03 | 22 | 85 | 2 | C2931822 | |
| Disease | Intellectual Disability | 1.87e-03 | 447 | 85 | 6 | C3714756 | |
| Disease | mean reticulocyte volume | 2.14e-03 | 799 | 85 | 8 | EFO_0010701 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.17e-03 | 24 | 85 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.17e-03 | 24 | 85 | 2 | C3805278 | |
| Disease | platelet measurement | 2.19e-03 | 315 | 85 | 5 | EFO_0005036 | |
| Disease | creatinine measurement | 2.26e-03 | 995 | 85 | 9 | EFO_0004518 | |
| Disease | Neurodevelopmental Disorders | 2.48e-03 | 93 | 85 | 3 | C1535926 | |
| Disease | Cholangiocarcinoma | 2.55e-03 | 26 | 85 | 2 | C0206698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDSQGDLRMADGVAN | 276 | Q9H0P0 | |
| AGSDVFDGDLGMGAA | 1081 | P04626 | |
| VGQGAMDDGGGAFIS | 296 | Q9Y646 | |
| EMGAGDGLAMTGAVQ | 46 | Q9NRR8 | |
| INDGMGGDGDDMEIF | 56 | Q00994 | |
| MEDGDSGIEGAEGAG | 301 | Q7L8J4 | |
| VDLGSAQGDGLMAGN | 471 | Q9H981 | |
| AQGDGLMAGNDSEEA | 476 | Q9H981 | |
| ALRAGNDSAMADGEG | 26 | Q8WXI4 | |
| AMGAVAGQEDGFEGT | 16 | Q9UKU9 | |
| AAGGQQAAAGMGLGK | 546 | Q8NFD5 | |
| AEVMDVGSGGDGQSE | 46 | Q8WYQ5 | |
| AEQRGTDMLADGGDG | 1831 | Q9P2D1 | |
| TDMLADGGDGGEFDR | 1836 | Q9P2D1 | |
| GGGRDMFASVGADGS | 186 | P61962 | |
| EKMAEGGSGDVDDAG | 36 | Q9UH62 | |
| MGGEAGCAAAVGAEG | 1 | Q8NCT1 | |
| AQMAGGFDEKAGGAQ | 181 | P02458 | |
| SGDGFGDEGAAGEMI | 201 | Q9H4I0 | |
| MAAALGASGGAGAGD | 1 | Q96EV2 | |
| QGGGGLAMNDRAAAA | 311 | Q9Y2U8 | |
| GGEAAAAAAAERGEM | 36 | O14497 | |
| ADDNLGSMAEEGRAG | 421 | O60840 | |
| MGKGGNQGEGAAERE | 1 | O95864 | |
| LAMDFGGAGAAQQGL | 476 | Q13310 | |
| MNGGNESSGADRAGG | 1 | Q96DN6 | |
| LMVAKEEGDGAAGAG | 116 | P83369 | |
| TQGVNDGDMRLADGG | 16 | Q08380 | |
| DGDMRLADGGATNQG | 21 | Q08380 | |
| ALGAAMAAGAAEGVD | 456 | Q14409 | |
| SGGGMVEQVSGDCDD | 486 | P78333 | |
| NEEDIGAGDQGLMFG | 126 | P31153 | |
| GSDGMGGDGSEFLQR | 251 | O94992 | |
| DNGFGMGSDDVEKVG | 56 | Q9UHC1 | |
| ANMGGLAAGADAAYI | 591 | Q01813 | |
| GGGMDQSISFLAEEG | 186 | Q01415 | |
| GDQMELGEENGAAGA | 101 | Q00839 | |
| ALDAEMLEDEAGGGG | 36 | Q1KMD3 | |
| MRDADADAGGGADGG | 1 | Q14657 | |
| NEEDVGAGDQGLMFG | 126 | Q00266 | |
| SGADLNMDIGVSGFG | 4481 | P98164 | |
| SAAGEGGDAGRMDTE | 36 | Q9NRX1 | |
| GEGGAMMGLGASDFE | 676 | A2A3N6 | |
| MAKGEGAESGSAAGL | 1 | Q8NA29 | |
| MGGSALNQGVLEGDD | 1 | O75344 | |
| AMEGLGMDEGDGEGN | 156 | P40855 | |
| DEDGGGRAGSAMAIG | 151 | A0A2Z4LIS9 | |
| MEFAAENEGKSGGGL | 1 | Q9NWK9 | |
| AGNDMGNDDAIGGNV | 11 | Q5VU57 | |
| NGETSVEEMGGAVGG | 161 | Q9UH90 | |
| NVETALSSMGGGGDA | 1761 | Q14204 | |
| GEGGAMLGLGASDFE | 191 | P55036 | |
| DDMEGSAAGDVSGAG | 4591 | P21817 | |
| RGEGGNGLLAAMEEA | 2336 | Q92736 | |
| GGMDQDIFDINEGLG | 31 | Q16820 | |
| FSGMNGDLEEEGGRE | 366 | Q9UHG0 | |
| GGADFEAMEQLDADG | 451 | Q99829 | |
| SAGAMLGGDLNSANG | 201 | Q14814 | |
| MAPEEDAGGEALGGS | 1 | Q9UKS6 | |
| AAGGALVGMKAVGDD | 1261 | Q6ZRI0 | |
| MSEEQFGGDGAAAAA | 1 | Q14103 | |
| TAAVGGSAGEQEGAM | 16 | Q14103 | |
| DEDGGGRAGSAMAIG | 66 | O43524 | |
| GAAEGGAARTAGGMA | 256 | Q8TC56 | |
| GAGAADGMEEPGRNA | 31 | P30872 | |
| MTAGGQAEAEGAGGE | 1 | Q76EJ3 | |
| EGELMEDAAAAGPAG | 571 | O94972 | |
| DAAGEIMGRGGDNVQ | 426 | Q9H8W5 | |
| MGGAGGEGSDDDTSL | 276 | Q9Y365 | |
| GASDGGGGEARAMDE | 41 | Q92581 | |
| EVDGMAGNEDRGGIQ | 721 | P35251 | |
| AAAEEVMAEGGAQGG | 21 | Q96NT1 | |
| VMAEGGAQGGDCDSA | 26 | Q96NT1 | |
| MAATEGVGEAAQGGE | 1 | P49354 | |
| AGGKENGQMAVSDGS | 211 | Q6ZNJ1 | |
| LFDGHAGGGAAEMAS | 156 | Q5JR12 | |
| DSEGGAAGGEADMDF | 26 | Q8IXJ6 | |
| GADGMGIFDLLDTGD | 1991 | Q9UHV7 | |
| GGSLAGNEMINGEDE | 786 | P35712 | |
| MTKNIGDDGGGDDNT | 296 | Q8TDI8 | |
| MSGAGVGGASEESQA | 1 | Q67FW5 | |
| AAGEELGNEAGAGAM | 426 | Q96PV4 | |
| HLGGGDDSDGADMIA | 446 | Q15735 | |
| EVMEGADNQGAGEQG | 216 | P67809 | |
| MADGKGDAAAVAGAG | 1 | Q13129 | |
| MAERGGDGGESERFN | 1 | O14776 | |
| MGDEGEDSNEGTGSA | 1981 | P12270 | |
| GDMAFEGDMGAAGGD | 201 | Q9BQI7 | |
| EMLANTGENGGEGAA | 81 | Q15413 | |
| EEMAALDVDSGGGGG | 11 | Q02447 | |
| MENAGGAEGTESGAA | 1 | Q5TAB7 | |
| MADRGGVGEAAAVGA | 1 | Q8TDW4 | |
| KASGEGMAGDAAGET | 1356 | O95359 | |
| GMAGDAAGETEGSME | 1361 | O95359 | |
| MADRDSGSEQGGAAL | 1 | Q00577 |